There are 2789 resources available
45P - Analysis of HER2 distribution concordance in breast cancer tissue by serial IHC staining
Presenter: Guan-Ru Peng
Session: ePoster Display
Resources:
Abstract
46P - Intraperitoneal perfusion with sodium bicarbonate solution can significantly increase the lifespan of mice with Ehrlich ascites carcinoma
Presenter: Alexey Bogdanov
Session: ePoster Display
47P - Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01
Presenter: Michele Droz Dit Busset
Session: ePoster Display
48P - (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial
Presenter: Eric Assenat
Session: ePoster Display
100P - Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
Presenter: George Demetri
Session: ePoster Display
101P - The landscape of MET alterations in European cancer patients
Presenter: Jürgen Wolf
Session: ePoster Display
102P - NTRK test usage practices in Europe and Asia: Findings from a real-world study
Presenter: Kriti Jindal
Session: ePoster Display
103P - Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of age
Presenter: Stefania Zovato
Session: ePoster Display
104P - Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
Presenter: Jesus Garcia-Foncillas
Session: ePoster Display
105P - Prognostic value of the NTRK fusion biomarker in the Netherlands
Presenter: Irene Santi
Session: ePoster Display